Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown ...
Technetium-99m, a critical nuclear imaging radioisotope, is in short supply and could cause delays or cancellations of over 40,000 medical imaging studies daily in the United States. The global ...
CENTENNIAL, Colo.--(BUSINESS WIRE)--Cell>Point announced today that it has received a letter from the U.S. Food and Drug Administration (FDA) indicating agreement on a Special Protocol Assessment (SPA ...
About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...
Tackling supply shortages: As the supply chain for medical radioisotopes continues to struggle, researchers are developing new methods for producing technetium-99m, and exploring the potential of ...
LONDON, Feb. 23, 2022 /PRNewswire/ -- Theragnostics announces that NephroScan, its radiodiagnostic imaging drug used as an aid for the evaluation of renal parenchymal disorders in adult and pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback